| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.009 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |